News › Pharmaceuticals  ·  24 Apr 2026, 6:07 PM IST  ·  3 months ago

stay constructive on Dip: Pharma, Power, Metals Favored; Avoid IT Stocks

Bias: Bullish +4690% confidencePharmaceuticalsPower

In one line — For banking, monitor asset quality and credit growth trends; a bullish bias could emerge if Nifty Bank holds 55,000, but.

Bearish
Bullish
−1000+46+100

Source: Economic Times · AI-summarised by Anadi · Updated 24 Apr 2026, 6:37 PM IST

Pharmaceuticalswatching
Powerwatching
Metalswatching
Information Technologywatching
Bankingwatching

What Happened

A market expert, Rudramurthy BV, suggests that the current Indian market correction is healthy and presents a 'stay constructive on dip' opportunity. He pinpoints specific Nifty and Bank Nifty levels for entry, while also providing sector-specific recommendations, advising investors to back pharma, power, and select metals, but to avoid IT.

Why It Matters (for you)

This analysis provides actionable guidance for traders amidst market volatility, offering specific entry points and sector preferences. It aligns with the broader market sentiment where IT stocks have been under pressure, and sectors like power and metals have shown resilience, making it relevant for portfolio adjustments.

Impact on Indian Markets

The advice is broadly positive for the Pharmaceuticals, Power, and Metals sectors, potentially leading to increased buying interest in stocks within these industries. Conversely, the caution against IT stocks could reinforce negative sentiment, potentially leading to continued selling pressure or underperformance for companies like TCS, INFY, WIPRO, and HCLTECH.

What Traders Should Watch Next

Traders should monitor Nifty and Bank Nifty's price action around the suggested levels (Nifty 23,700-23,800, Bank Nifty 55,000) for confirmation of upside potential. Also, observe the performance of pharma, power, and metals stocks for sustained strength, and IT stocks for any signs of a reversal or continued weakness.

Key Evidence

  • Indian markets are experiencing a healthy correction.
  • Advises waiting for Nifty 23,700-23,800 and Bank Nifty 55,000 for buying opportunities.
  • Highlights strength in pharma, power, and select metals.
  • Cautions against IT stocks.
  • Risk flag: Rising interest rates impacting NIMs